Deutsche Gesellschaft für Phlebologie

Kontaktdaten:

Prof. Dr. med. Dipl. Phys.
Thomas M. Proebstle

Privatklinik Proebstle
Dermatologie, Venenheilkunde, Derma-Ästhetik
P6, 26 (Auf den Planken)
68161 Mannheim - Deutschland

 

Tel.: +49-621 30 69 600
E-Mail: Diese E-Mail-Adresse ist gegen Spambots geschützt! JavaScript muss aktiviert werden, damit sie angezeigt werden kann.
Homepage: www.privatklinik-proebstle.de

 

• Mitglied der medizinischen Fakultäten der Universität Mainz
• Mitglied der medizinischen Fakultäten der Universität Pecs, Ungarn
• Mitglied der Faculty des American College of Phlebology

Akademische Abschlüsse
1989	Humanmedizin an der Universität Ulm
1991	Diplom Physik an der Universität Ulm
2006	Diploma in Aesthetic Lasermedicine, Univ. Greifswald

Beruflicher Werdegang
1983	Abitur am Bodenseegymnasium Lindau, Note 1.0
1989	Promotion an der Fakultät für Theoretische Medizin der Universität Ulm mit summa cum laude.
1989 - 1995	Facharztausbildung Dermatologie und Venerologie an der Universitätshautklinik Ulm
1995	Erlangung der Bereichsbezeichnung Phlebologie
1997	Erlangung der Weiterbildungsermächtigung Phlebologie
1998 -2004	Habilitation und Venia Legendi an der medizinische Fakultät der Universität Mainz für das Fach Dermatologie mit dem Thema: Minimal-invasive Operationstechniken in der Phlebochirurgie
2004 - 2007	Universitätsklinik Heidelberg, W3-Professur für operative Dermatologie und Phlebochirurgie
2007	Kündigung des Beamtenverhältnisses und Gründung der Proebstle Skin&Veins GmbH, privatärztliche Tätigkeit in Heidelberg, Wien und Zürich
2008	Gründung der Privatklinik Proebstle GmbH in Mannheim
2009	Ernennung zum Cimzetes Egyetemi Docensse (außerplanmäßiger Professor) auf Lebenszeit an der medizinischen Fakultät der Universität Pecs, Ungarn

Wissenschaftspreise
1990	Promotionspreis der Fakultät
1997	Peregrini-Preis der AG Phlebologie der Österreichischen Gesellschaft für Dermatologie für die Originalarbeit Proebstle TM, U Paepcke, G Weisel, S Gass, L Weber (1998) High ligation and stripping of the long saphenous vein using the tumescent technique for local anesthesia. Dermatol Surg, 24:149-53.
2003	Preis der Robert-Müller-Stiftung für die Publikation Proebstle TM, Lehr HA, Kargl A, Espinola-Klein C, Rother W, Bethge S, Knop J (2002) Endovenous treatment of the greater saphenous vein with a 940 nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser generated steam bubbles.JVascSurg 35:729-36

Publication list Thomas M. Proebstle
Original Papers
Impactfactor-total: 162,197

• Creton D, Pichot O, Sessa C, Proebstle TM. Radiofrequency powered segmental thermal obliteration carried out with the closure fast procedure: results at one yea. Ann Vasc Surg 2010, Jan 27. [Epub ahead of print] IF 1,262 /C
• Eklof B, Perrin M, Delis KT, Rutherford RB, Gloviczki P - Proebstle TM part of the consensus group: Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg. 2009 49:498-501. IF 3,770 /A
• Proebstle TM, Vago B, Alm J, Göckeritz O, Lebard C, Pichot O. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental ablation: first clinical experience. J Vasc Surg 2008; 47:151-6. IF 3,770 /A
• Proebstle TM, Herdemann S. Early Results and Feasibility of incompetent perforator vein ablation by endovenous laser treatment. Dermatol Surg 2007; 33:162-56. IF 2,102 /B
• Proebstle TM, Moehler T, Herdemann S. Reduced Recanalization Rates of the Great Saphenous Vein after Endovenous Laser Treatment with Increased Energy Dosing - definition of a Threshold for the Endovenous Fluence Equivalent. J Vasc Surg 2006; 44:834-9. IF 3,770 /A
• Proebstle TM, Moehler T, Herdemann S. Reduced Recanalization Rates of the Great Saphenous Vein after Endovenous Laser Treatment with Increased Energy Dosing - definition of a Threshold for the Endovenous Fluence Equivalent. J Vasc Surg 2006; 44:834-9. IF 3,770 /A
• Proebstle TM, Moehler T, Guel D, Herdemann S. Endovenous laser treatment of the greater saphenous vein using a 1320 nm laser causes less side effects than using a 940 nm diode laser. Dermatol Surg 2005; 31:1678-83. IF 2,102 /B
• Proebstle TM. Dosing of laser energy and treatment success in endovenous laser treatment (ELT). Phlebol Dig 2005; 18:4-7.
• Keilholz U, Punt CJ, Gore M, Kruit W, Patel P, Lienard D, Thomas J, Proebstle TM, Schmittel A, Schadendorf D, Velu T, Negrier S, Kleeberg U, Lehman F, Suciu S, Eggermont AM. Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. J Clin Oncol. 2005;23:6747-55 IF 17,157 /A
• Voit C, Kron M, Rademaker J, Schwurzer-Voit M, Sterry W, Weber L, Ozdemir C, Proebstle T, Keilholz U. Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol. 2005;23:1218-27 IF 17,157 /A
• Proebstle TM, Gül D, Kargl A, Knop J (2004) Non-Occlusion and early reopening of the great saphenous vein after endovenous laser treatment is fluence dependent. Dermatol Surg 30:174-8. IF 2,102 /B
• Proebstle TM, Gül D, Lehr HA, Kargl A, Knop J (2003) Infrequent early recanalization of the greater saphenous vein after endovenous laser treatment. J Vasc Surg 38:511-6. IF 3,770 /A
• Proebstle TM, Gül D, Kargl A, Knop J (2003) Endovenous Laser Treatment of the Lesser Saphenous Vein with a 940 nm Diode Laser - Early Results. Dermatol Surg 29:357-61. IF 2,102 /B
• Schmittel A, Proebstle TM, Engenhardt-Calibic R, Scheibenbogen C, Geueke AM, Thiel E, Keilholz U (2003) Brain metastases following interleukin-2 plus interferon-alpha 2a therapy: a follow-up study on 94 stage IV melanoma patients. Eur J Cancer 39:476-80. IF 4,457 /B
• Proebstle TM, Kargl A, Espinola-Klein C, Savvidis S, Knop J, Schmiedt W (2002) Implantation eines bovinen Venenklappen-Xenografts in die Vena femoralis communis bei Patienten mit postthrombotischen Syndrom. Phlebologie 31:132-6. IF 1,058 /C
• Proebstle TM, Schneiders V, Knop J (2002) Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg 28:1022-6. IF 2,102 /B
• Proebstle TM, Bethge S, Barnstedt S, Kargl A, Knop J, Sattler G (2002) Subfascial endoscopic perforator surgery with tumescent local anesthesia. Dermatol Surg, 28:689-93. IF 2,102 /B
• Szeimies RM, Karrer S, Radacovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C, Sidoroff A, Hempel M, Ulrich J, Proebstle TM, Meffert H, Mulder M, Salomon D, Dittmar HC, Bauer JW, Kernland K, Braathen L (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared to cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 47:258-62. IF 4,081 / A
• Proebstle TM, Sandhofer M, Kargl A, Gül D, Rother W, Knop J, Lehr HA (2002) Thermal damage of the inner vein wall during endovenous laser treatment: key role of energy absorption by intravascular blood. Dermatol Surg, 28:596-600. IF 2,102 /B
• Proebstle TM, Lehr HA, Kargl A, Espinola-Klein C, Rother W, Bethge S, Knop J (2002) Endovenous treatment of the greater saphenous vein with a 940 nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser generated steam bubbles. J Vasc Surg 35:729-36. IF 3,770 /A
• Voit C, Mayer T, Kron M, Schoengen A, Sterry W, Weber L, Proebstle TM (2001) Efficacy of ultrasound B-scan compared to physical examination in follow-up of melanoma patients. Cancer 91:2409-16. IF 5,238/ A
• Voit C, Proebstle TM, Winter H, Kimmritz J, Kron M, Sterry W, Schwürzer M (2001) Presurgical ultrasound-guided anchor-wire marking of soft tissue metastases in stage III melanoma patients. Dermatol Surg, 27:129-32. IF 2,102 /B
• Voit C, Mayer T, Proebstle TM, Schwürzer-Voit M, Kron M, Weber L, Kron M, Sterry W, Schoengen A (2000) Ultraschallunterstützte Feinnadelaspirationszytologie (FNAC) unklarer Raumforderungen bei Melanompatienten. Ultraschall in Med, 21:218 - 222.
• Voit C, Mayer T, Proebstle TM, Weber L, Kron M, Krupienski M, Zeelen U, Sterry W, Schoengen A (2000) Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases. Cancer 90:186-193. IF 5,238/ A
• Proebstle TM, Jiang W, Keilholz U, Högel J, Weber L, Voit C (2000) Correlation of positive RT-PCR for tyrosinase in peripheral blood of malignant melanoma patients with clinical stage, survival and other risk factors. Br J Cancer, 82:118-123. IF 4,846 /B
• Proebstle TM, Weisel G, Voit C, Peter RU (1999) Die Fasziotomie im Rahmen der endoskopischen Perforansdiszision bei Ulcus cruris venosum. Hautarzt, 50:66-571 IF 0,362 /C
• Voit C, A Schoengen, M Schwürzer, L Weber, T Mayer, TM Proebstle (1999) Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine needle aspirates. Brit J Cancer, 80:1672 - 1677. IF 4,846 /B
• Proebstle TM, T Fuchs, C Scheibenbogen, W Sterry, U Keilholz (1998) Long-term outcome of treatment with dacarbazine, cisplatin, interferon-alpha and intravenous high-dose interleukin-2 in poor risk melanoma patients. Melanoma Res, 8: 557-63. IF 2,336 /B
• Voit C, A Schoengen, L Weber, TM Proebstle (1998) Identification of melanoma metastasis by tyrosinase-reverse transcription-polymerase chain reaction of fine needle aspirates. J Am Acad Dermatol, 39, 1030-32. IF 4,081 / A
• Proebstle TM, G Weisel, U Paepcke, S Gass, L Weber (1998) Light reflection rheography and clinical course of patients with advanced venous disease before and after endoscopic subfascial division of perforating veins. Dermatol Surg, 24:771-776. IF 2,102 /B
• Proebstle TM, U Paepcke, G Weisel, S Gass, L Weber (1998) High ligation and stripping of the long saphenous vein using the tumescent technique for local anesthesia. Dermatol Surg 24:149-53. IF 2,102 /B
• Keilholz U, SH Goey, CJA Punt, TM Proebstle, R. Salzmann, C. Scheibenbogen et al (1997) Interferon-alpha and interleukin-2 with or without cisplatinum in metastatic melanoma: a randomized trial of the EORTC Melanoma Cooperative Group. J Clin Oncol 15: 2579-2588. IF 17,157 /A
• Kramer M, L Weber, TM Proebstle (1996) Epidemiologische Daten zum malignen Melanom im Einzugsbereich der Universitätshautklinik Ulm. Zschr Hautkr 71: 687-694.
• Proebstle TM, Scheibenbogen C, Sterry W, Keilholz U (1996) A phase II study of DTIC, CDDP, alfa-interferon and high-dose IL-2 in 'poor-risk' metastastic melanoma. Eur J Cancer 32A: 1530 - 33. IF 4,457 /B
• Proebstle TM, Huber R, Sterry W (1996) Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase mRNA. Eur J Cancer 32A:1664-67. IF 4,457 /B
• Schwürzer-Voit M, Proebstle TM, Sterry W (1996) Identification of lymph node metastases by use of PCR in melanoma patients. Eur J Cancer 32A:264-68. IF 4,457 /B
• Proebstle TM, Schwürzer-Voit M, Ahlert Th, Kaufmann R, Sterry W (1995) Aktiv spezifische Immuntherapie (ASI) und Antisuppressiv-therapie in Kombination mit Monochemotherapie bei metastasiertem Melanom. Zschr Hautkr, 70:503-506.
• Proebstle TM, Mitrovics M, Schneider M, Hombach V, Rüdel R (1995) Recombinant interleukin-2 acts like a class I antiarrhythmic drug on human cardiac sodium channels. Pflügers Arch - Eur J Physiol 429:462-469. IF 3,562 /B
• Schneider M, Proebstle TM, Hombach V, Hannekum A, Rüdel R (1994) Characterization of the sodium currents in isolated human cardiocytes. Pflügers Arch - Eur J Physiol 428:84-90. IF 3,562 /B
• DeLuca A, Proebstle TM, Brinkmeier H, Rüdel R (1991) The different use dependences of tocainide and benzocaine are correlated with different effects on sodium channel inactivation. Naunyn-Schmiedebergs Arch Pharmacol 344:596-601. IF 2,830 /B
• Proebstle TM, Rüdel R Ruppersberg JP (1988) Hodgkin Huxley parameters of the sodium channels in human myoballs. Pflügers Arch - Eur J Physiol 412:264-69. IF 3,562 /B

B. Übersichtsartikel / Reviews

1. Nijsten T, van den Bos RR, Goldman MP, Kockaert MA, Proebstle TM, Rabe E, Sadick NS, Weiss RA, Neumann MH. (2009) Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol. 60:110-9.
2. Proebstle TM. (2008) Treatment of the incompetent GSV by modern endovascular techniques. Phlebol Digest, 21:4-7.
3. Proebstle TM, Pannier FM, Schuller-Petrovic S, Offermann M, Hohenleutner U, Rabe E (2004) Konsensus zur endovenösen Lasertherapie der Varikose. Phlebologie 33: 106-109.
4. Proebstle TM (2003) Die endoluminale Lasertherapie (ELT) der Stammvarikose. Haut 14:298-302.
5. Guel D, Proebstle TM (2003) Neue Techniken der Phlebologie - Endoluminale Lasertherapie (ELT) der Varikose. Der Deutsche Dermatologe 51:916-20.
6. Proebstle TM (2003) Endovenöse Lasertherapie (ELT) der Varikose. Phlebologie 32:131-7.
7. Proebstle TM (2003) Operative Ulkustherapie. Hautarzt 54:379-88.
8. Proebstle TM (2002) Endovenöse Lasertherapie (EVLT) der Vena saphena magna mit dem 940 nm Diodenlaser. Vasomed 14: 98-104
9. Voit C, Schoengen A, Schwürzer-Voit M, Weber L, Sterry W, Proebstle TM (2002) The role of ultrasound in detection and management of regional disease in melanoma patients. Sem Oncol,19:353-60.
10. Schirrmacher V, Ahlert T, Proebstle TM, Steinert HH, Herold-Mende C, Gerhards R, Hagmüller E (1998) Immunization with virus modified tumor cells. Sem Oncol, 25: 677-696.

C. Casuistics

• Oblinger E, A Cibis, RU Peter, TM Proebstle (1997) Genito-anale Condylomata acuminata, mukokutane Candidose, Vitiligo, Keratopathie und primärer Hypoparathyreoidismus bei autoimmunem polyglandulärem Syndrom Typ 1 (APECED), Dtsch Med Wschr, 122:1382-85.
• Proebstle TM, Lorenz H, Gall H (1996) Bisulfit-induziertes pseudoallergisches Asthma bronchiale. Notarzt 12:127-130.
• Bredlich RO, S Stracke, H Gall, TM Proebstle (1997) Heparin-assoziiertes Thrombozyten-Aggregationsyndrom mit Hautnekrosen bei Hämodialyse, Dtsch Med Wschr, 122:328-32.
• Proebstle TM, Gall H, Jugert FK, Merk HF, Sterry W (1995): Specific IgE and IgG serum antibodies to thiamine associated with anaphylactic reaction. J Allergy Clin Immunol, 95:1059-1060.
• Proebstle TM, Winter T, Hansen-Schmidt F, Weber L, Sterry W (1995) Calciphylaxie, Dtsch Med Wschr, 120:1080-1084.
• Proebstle TM, Jugert FK, Merk HF, Gall H (1995) Severe anaphylactic reaction to local administration of framycetin, J Allergy Clin Immunol, 96: 429-430.
• Proebstle TM, Schönfeldt C, Lüttke B, Weber L (1996) Primär zerebrale Manifestation eines Morbus Behcet. Dtsch Med Wschr, 121:16-20.

D. Buchkapitel / Book Chapters

• Proebstle TM (2008), Percutaneous Laser Therapy of telangiectasias and varicose veins. Chapter 34, pp. 386 - 95. In Gloviczki P (Ed.) Handbook of Venous Disorders 3rd Edition, Hodder Arnold, London UK .
• Proebstle TM, (2007), Endovenous Laser (EVL) for saphenous vein ablation. Chapter 29, pp. 267 - 73. In Bergan J (Ed.) The Vein Book, Elsevier Academic Press,London, UK.
• Proebstle TM, (2006) Ultraschall bei der endovasalen Therapie der Varikose mit thermischen Verfahren - Laser und Radiofrequenzobliteration. In Mendoza E (Ed.) Ultraschall in der Phlebologie, Springer, in press.
• Pannier-Fischer F, Proebstle TM (2003) Endovenöse Laserbehandlung der Varikose. In: Rabe E (Hrsg). Grundlagen der Phlebologie. 3. Auflage, Köln: Viavital 2003.
• Proebstle TM, Weber L (1998) Autologer Lipotransfer bei Sclerodermie en coup de sabre und Parry-Romberg-Syndrom, S. 302 - 4. In Ästhetische Chirurgie, Band II: Laserchirurgie, Plastiken und Implantate. Mang WL, Kokoschka EM (Hrsg.). Einhorn Presse Verlag Reinbek.
• Proebstle TM, Fakler J, Kaufmann R, Sterry W (1995) Chemoimmuntherapie mit IV-Interleukin-2 plus Radiatio bei Melanompatienten mit ZNS-Metastasierung. VOD-Jahrbuch 1995
• Kaufmann R, Proebstle TM, Sterry W (1995) Therapie von Melanomen. Onkologie, Eds. Zeller, Zurhausen. EcoMed Verlag.
• Proebstle TM, Schwürzer-Voit M, Ahlert Th, Sterry W (1995) Adjuvante, autologe aktiv spezifische Immuntherapie (ASI) des metastasierenden malignen Melanoms im klinischen Stadium III und IV (UICC) - eine prospektiv randomisierte Doppelblind-Studie. In Tilgen, Hrsg., VOD-Jahrbuch 1994.

F. Wissenschaftliche Kongresse / Scientific Conferences

Organisation, Faculty, Presentations (Selection of National and International Events)

• 2010

  • May 12th - 14th , International Vein Conference, Miami, Invited Faculty, Speaker www.ivc2010.com
  • May 12th - 14th , International Vein Conference, Miami, Invited Faculty, Speaker www.ivc2010.com
  • April 12th , 32nd Charing Cross Meeting, London, England, Invited Workshop Co-Conducor, www.cxsymposium.com
  • March 26-27th , 10th Sclerotherapy 2010, Associazone Flebologica Italiana, Bologna, Italy, Invited Speaker, Chairman www.valet.it
  • February 25th -26th, European Vascular Course, Invited Faculty, Chairman, Speaker www.2010.cardiovascular-course.eu
  • February 18th , 16. Bonner Venentage, Bonn, Germany, Speaker “Endovenöser Laser, 1320 nm” www.viavital.net/16-bonner-venentage-1902-20022010
  • January 21th-23st, Controversies and Updates in Vascular Surgery 2010", Paris, Invited Speaker, Venous Session, Accessoric saphenous veins in endothermal ablation, should they be treated concomitantly with the Great saphenous? www.cacvs.org
  • January 14th, IROS 2010, Annual Meeting of the German Speaking Societies of Interventional Radiology, Munic, Germany Invited Speaker, Venöse Insuffizienz I: “Laserablation pro-contra" www.irosonline.org
  • January 11th , IMCAS, Paris, Workshop Conductor, Speaker “New Devices Session” ProLipo Plus and TempASSURE: Temperature controlled High Power Laser with a tuneable blend of 1319 nm and 1064 nm www.imcas.com

• 2009

  • November 5th -8th , American College of Phlebology, Annual Meeting Palm Desert, California, Invited Faculty, Speaker and Workshop Conductor, www.acpcongress.org
  • October 8-10th , International Symposium on Vein Disease 2009, Abano, Italy, Invited Speaker, Chairman. “Treatment of telengiectasias and reticular veins” and “Endovenous Radiofrequency ablation”
  • August 31st - 04th September, UIP - Phlebology World Conference, Monte Carlo, Monaco, Science Advisory Board, Invited Faculty, Chairman, Speaker, Workshop Conductor. “Ask the Expert Session” www.uip2009.eu/amonaco
  • June 27th -30th , Mayo Clinic International Vascular Symposium 2009, Budapest, Hungary, Invited Faculty, Speaker, Panelist, Chronic Venous Disease: Surgical and Endovascular Management, “2 year results of endothermal ablation of the saphenous vein with the latest generation of radiofrequency catheters”.
  • June 5th -7th, European Venous Forum 2009, Copenhagen, Denmark, Invited Faculty, Speaker, Panelist, “Contraindications and pitfalls: radiofrequency ablation”, www.europeanvenousforum.org/evf2009
  • May 7th -9th , International Vein Conference Miami, FL, USA, Invited Faculty, Panelist, Speaker, “How does energy interact with the vein wall”, Perforator Ablation with the RF Device vs Laser” , “Office based Cosmetic Procedures” www.ivcmiami.com
  • April 28th -May 1st , 126. Annual Meeting of the German Surgical Society, Munic, Invited Speaker “Stand der Lasertherapie bei der primären Varikose”, www.chirurgie2009.de
  • April 4th-7th l, Charing Cross 31st International Symposium, Vascular and Endovascular Controversies Update, London, England, Invited Panelist “Question Time: Venous”, Tutor “Venous Workshop”, www.cxsymposium.com
  • February 27th-28th , 15. Bonner Venentage 2009, Bonn, Germany, Invited Speaker „Update Closure Fast“
  • 26th -28th February, European Venous Course, Maastricht, Netherlands, Invited Faculty, Chairman and Speaker “How to do it - Saphenous Veins”, www.cardiovascular-course.eu
  • February 11th -14th, 21st Annual Meeting of the American Venous Forum, Phoenix, Arizona, Invited Chairman and Speaker Session “Exotic Veins”, www.veinforum.org
  • January 30th-31st, Controversies and Updates in Vascular Surgery 2009", Paris, Invited Chairman Venous Session, www.cacvs.org

• 2008

  • December 6th , Darmstädter Live-Symposium, Darmstadt, Germany Workshop Co-Convener „Advanced Botulinumtoxin- with Combination Treatments”
  • November 28th, Münchner Gefäß-Gespräch/Heidelberger Heißes Eisen, Munic, Germany. Invited Speaker „Update Laserobliteration“
  • November 28th, 5th meeting on Endovenous Treatment of Varicous Veins. Dept of Vascular Surgery, Sagrat Cor University Hospital, Barcelona, Spain. Invited Speaker, “The new radiofrequency techniques are better than laser in varicose veins treatment?”
  • November 14th -15th , Joint Annual Meeting Austrian Society for Angiology, Austrian Society for Phlebology, Vienna, Austria, Invited Speaker „Überblick über die EVO mit Laser“, www.phlebologie-gesellschaft.at
  • November 6th -9th , American College of Phlebology, Marco Island, Florida. Speaker Scientific Session, “One and Two Years Follow-Up of Radiofrequency Segmental Thermal Ablation (RSTA) of Great Saphenous Veins”, www.phlebology.org
  • November 06th , Mexican Phlebological Society, Annual Meeting, Los Cabos, Mexico. Invited Speaker
  • October 24th , Annual Meeting of the Czech Society of Phlebology, Prague, Czech Republic, Invited Speaker “RF ablation of varicose veins“.
  • October 2nd -5th , Annual Meeting International Society of Dermatological Surgery, Las Vegas, USA, Invited Faculty, Workshop Convenor, Speaker, www.isdsworld.com
  • September 17th , Annual Meeting of the European Academy of Dermatology, Paris, France, Symposium Task Force Phlebology, Invited Speaker “Ultrasound guided therapies” www.eadv2008.com
  • September 11th-13th , Annual Meeting I.V.F., Ferrara, Italy, Invited Faculty, Speaker, Endovenous Laser Treatment, www.isvd2008.com
  • September 5th-7th , Annual Meeting European Society of Vascular Surgery, Nice, France, Invited Faculty, Workshop Convenor “Endovenous Treatments”, Speaker Symposium IV, www.ESVS.org
  • July 20th-25th, 21. Fortbildungswoche für praktische Dermatologie, München, Kurs Botulinumtoxin I: Grundlagen, Speaker/Practical demonstration „Stirn und Glabella bei Männern“ www.fortbildungswoche.de
  • May 30th-31st , Annual Meeting of the Benelux Society of Phlebology, Maastricht, Belgium, Invited Faculty, Chairman, Speaker, “First 2-year results of Closure Fast ablations of GSVs”. www.phlebologybenelux.org
  • 16th May, European Vascular Course 2008, Amsterdam, Netherlands, Panelist, Speaker Venous Symposium New developments in RF Ablation, “Two-year results of closure Fast ablation of the great saphenous vein” www.evc-meeting.com
  • 17.-19. April, 6th International vein Congress, Miami, Florida, USA, Invited Faculty Speaker, “Laser Physics”, “RF, Laser Wavelengths and Tips”, www.ccmcme.com/ivc2008
  • April 12th , 2nd International Congress on Anti-aging and Preventive medicine, Portorož, Slovenia, Invited Speaker “Injectable Fillers - Risks and Benefits” www.anti-aging2008.org.
  • January 19th , Controversies et Actualités en Chirurgie Vasculaire, Paris, France, Invited Speaker “Closure fast: results” , www.cacvs.org

• In 2007

  • 26-27th October, Workshop en cursus Flebologie; “de Varix; van Richtlijn tot DBC” Maastricht, Netherlands, Speaker, Workshop Convenor, Patient Live-Treatment “Closure Fast” www.spataderenvrij.nl/persbericht_071029.php
  • September 25th -29th, Conference President of the 49th Annual Meeting of the German Phlebological Society, Mainz Germany, www.phlebology.de/Aktuelles-/-News/einladung-zur-49-jahrestagung-der-dgp-vom-26-bis-29-september-2007.html
  • June 7th , Annual Meeting of the German Dermatological Laser Society (DDL), Karlsruhe, Germany, Convener of Workshops “Fractional Photothermolysis” and “Thermage”.
  • 17th - 20th May, 5th International Vein Congress IVC, Miami, Florida, USA, Faculty Speaker, “Colsure Fast -RF in 3 minutes”, “How does laser energy close veins”, www.ccmcme.com/ivc2007
  • May 1st , Gesellschaft für Ästhetische Chirurgie Deutschland, Kampen, Sylt, Germany, Convenor Workshop “Fractional Photothermolysis”.
  • April 30th Jahrestagung der Deutschen Dermatologischen Gesellschaft, Dresden, Mai 2007, Vorsitz und Organisation der Session Operative Phlebologie
  • April 14th-17th , 29th Charing Cross International Symposium, London, England, Invited Speaker, Panelist, Standard surgery for varicose veins still wins - against www.cxsymposium.com
  • February 14th-17th, 19th American Venous Forum, San Diego, California Speaker, “A Novel Type of Endovenous Catheter for the Treatment of Great Saphenous Vein Reflux Combines Favorable Aspects of RF Closure and Endovenous Laser: First Clinical Experience” www.veinforum.org/index.php?page=2007-meeting
  • January 25th . - 26th . January, Venalpina V, Schruns, Austria, Function: Session Chairman, Invited Speaker, „Varizen: endovenöse Obliteration“.
  • January 20th , Controversies et Actualités en Chirurgie Vasculaire, Paris, France Invited Speaker ” Wavelength 940nm vs. 1320 nm :Energy and results in endovenous laser”

• In 2006

  • November 09th-12th , Annual Meeting of the American College of Phlebology, Jacksonville, Florida, USA, Faculty member, Invited Speaker, “Feasibility of incompetent perforator vein ablation by endovenous laser treatment” and “Exceeding a threshold of 20 Joule/cm2 for the Endovenous Fluence Equivalent (EFE) Reduces Recanalization Rates of the Great Saphenous Vein after Endovenous Laser Treatment to a Minimum”
  • October 27th , Annual Meeting of the Dermatologic Surgery Working Group of the Austrian Society of Dermatology, Meran, Italy, Invited Speaker “Thermage and Fractional Photothermolysis: Minimally invasive structural improvement of the skin”
  • October 8th , Annual Meeting German Society of Phlebology, Rostock, Germany, Speaker, Conference President Elect,
  • April 14-16th, International Vein Congress, Miami, USA , Faculty, Invited Speaker “Laser- tissue interactions with endovenous ablation”, and ” Feasibility of ablation of incompetent perforators by endovenous laser treatment”
  • April 8th - 11th, 28th Charing Cross International Symposium, London, UK, Panelist “Abolition of reflux is best achieved by an endovascular method, Invited Speaker “Endovenous laser: comparison of different lasers”
  • February 2nd-6th, 18th Annual Meeting of the American Venous Forum, Miami, USA, Speaker “The One Year Recaalization Rate after Endovenous Laser Treatment of the Greater Saphenous Vein depends on the administered Linear Endovenous Energy Density”
  • February 17- 18th, Bonner Venentage, Bonn, Speaker „Langzeitergebnisse der endovenösen Lasertherapie“.
  • January 28th , Controversies et Actualités en Chirurgie Vasculaire - Technique ambulatoire dans la maladie variqueuse, Paris, France, Invited Speaker « Endovenous laser treatment of perforators « 

• 2005

  • 3rd-6th November, Annual Meeting of the American College of Phlebology, San Francisco, USA, Speaker, Panelist “Endovenous Laser Treatment of the GSV with 30 Watt Laser Power Produces Excellent Results at one Year”.
  • 15th October, ISDS Session at the EADV Annual Meeting, London, UK, Invited Speaker “Lasers in pigmented lesions. What lesions can be treated?”
  • 22-26th September, Annual Meeting International Society of Dermatologic Surgery (ISDS), Dublin, Ireland. Convener Phlebology Session, and Invited Speaker “Complications in Phlebosurgery” and “Energy and Success of endovenous laser treatment”.
  • 15th-17th September, Annual Meeting of the German Phlebological Society, Cologne, Germany, Convenor and Chairman Scientific Session, Live-Surgery, Invited Speaker “Endoluminale Lasertherapie und Radiowelle  - Bedeutung von Leistung und Energie”
  • 28. June, 12th International Symposium on Endovascular Techniques, Ajaccio, France,Invited Speaker “Endovenous Laser.Comparison of the Different Laser Procedures”
  • 4. June, Annual Meeting of the Swiss Phlebological Soociety, Locarno, Switzerland, Invited Speaker “Prinzipien und Technik des ELT and Ergebnisse und Komplikationen des ELT”
  • 22. April, Biannual Meeting Deutschen Dermatologischen Gesellschaft, Dresden, Germany, Chairman, Speaker, Convener Symposium „Operative Phlebologie“.
  • 14.-16. April, International Vein Congress, Miami, USA, Faculty, Invited Speaker “Does wavelength matter …810 nm / 940 nm / 980 nm?” and “Energy delivery and pullback rates during EVL … how does one decide?”
  • 1st April, International Workshop on Laser Treatment (EVLT), University Hospital UZ Leuven, Belgium, Live-Surgery, Invited Speaker.
  • 22. January, Controversies et Actualités en Chirurgie Vasculaire, Paris, France, Invited Speaker “Endovenous Laser: Experience of 1000 cases”
  • 15. Januar, Heidelberger Symposium, Heidelberg, Germany, Symposium Director, Speaker. „Radiowelle, Laser und Schaumsklerosierung: Indikation, Effizienz und Risiken“

• 2004

  • 4. - 7. November, Annual Meeting of the American College of Phlebology (ACP), Marco Island, Florida, USA. Speaker “Endovenous Laser Treatment of the GSV with a 30 Watt 940 nm Laser Produces Excellent Short Term Results” and ”Endovenous Laser Treatment of the Greater Saphenous Vein with a 1320 nm Nd:YAG-Laser is Highly Effective with only Moderate Side Effects”
  • 28. - 31. October, Darmstädter Live-Symposium, Frankfurt, Convenor Workshop „Varizentherapie“, Live-OP „endoluminale Varizentherapie“, Chairman „Dermatochirurgie III“, State of the Art Lecture „Varicose Vein Surgery“, Speaker „Komplikationen bei phlebologischen Eingriffen
  • 7.-10. October, Annual Meeting International Society of Dermatological Surgery (ISDS), Barcelona. Invited Speaker “Laser Energy and the Durability of Laser Closure of the Greater Saphenous Vein”
  • 02. October, Annual Meeting GELEV (groupe d’evaluation du laser et de l’echographie vasculaire), Strassbourg, France,Invited Speaker “Endovenous Laser Treatment (ELT) of the Greater Saphenous Vein (GSV) with a 940 nm Diode Laser - Energy, Power and Efficacy”
  • 23.-25. September, Annual Meeting German Society of Phlebology Recklinghausen. Chairman, Faculty Scientific Session IV: “Endovasale Therapie der Stammvarikose”. Chair and Convener Workshop IX: Endovasale Lasertherapie. Speaker „Endoluminale Lasertherapie (ELT) mit dem 940 nm Laser - Laserenergie und Effizienz der Methode“
  • 14.-15. May, International Conference: Surgery of Varicose Veins - State of the Art on Endovascular Treatments, Padua, Italy, Invited Speaker “How I do endovenous laser”
  • 09. - 10. Februar, Bonner Venentage, Bonn, Germany, Invited Speaker „Endovenöse Lasertherapie der Vena saphena parva“
  • 17. - 24. January, Venalpina und Jahrestagung der Schweizer Gesellschaft für Phlebologie,Chairman, Invited Speaker, „Endoluminale Lasertherapie“
  • 10. January, Mainzer Symposium: 3 Jahre endoluminale Lasertherapie der Stammvarikose (ELT) Qualitätssicherung. Symposium Director, Speaker.

• 2003

  • 24.-27. September, Annual Meeting of the German Society for Phlebology, Nürnberg, Speaker „Die endoluminale Lasertherapie der Stamm- und Seitenastvarikose - bereits ein neuer Standard?“
  • 18.-21. September, Annual Meeting of the International Society of Dermatological Surgery (ISDS), Berlin, Invited Speaker “Laser treatment of vascular problems vs. sclerotherapy and phlebectomy”
  • 27. - 31. August World Congress Union International Phlebologique (UIP), San Diego, USA, Invited Faculty, Chairman “Intravascular occlusion techniques” Speaker “Early recanalization of the greater saphenous vein after endovenous laser treatment”
  • 06. - 10. Mai, Biannual Meeting of the German Society of Dermatology, 2003, Speaker „Operative Dermatologie: Minimalinvasive endoluminale Techniken in der Therapie der Stammvarikose“ and „Phlebologie I (operativ) Endovasale Laserkoagulation - Erfahrungen und Bewertungen“
  • 14. - 15. February, Bonner Venentage, Bonn, Invited Speaker „Ergebnisse der endovenösen Lasertherapie der Stammvarikose nach 2 Jahren“.
  • 25. January, Mainzer Symposium, Mainz, „Endovenöse Laser-Therapie (EVLT) der Vena saphena magna.“ Symposium Director, Speaker „Rekanalisierung nach ELT (940 nm) der Vena saphena magna“

• 2002

  • 07.-10. November, Live-Symposium für operative Dermatologie, Darmstadt 2002, Live-Surgery “endoluminale Lasertherapie der Vena saphena magna”.
  • 25. October, Annual Meeting oft he German Phlebological Society, Mannheim, Speaker, „Implantation eines Einsegel-Venenklappen-Xenografts aus Rinder-Jugularvene in die Vena femoralis communis bei Patienten mit Ulcus cruris und postthrombotischem Syndrom: 18 Monate klinische Nachbeobachtung und Verlauf funktioneller Parameter.“
  • 18.-21. September, International Society of Dermatological Surgery (ISDS), Porto, Invited Speaker, “Endovenous laser treatment”
  • 12.-13. April, Annual Meeting of the Angiology Working Group of the German Dermatological Society, Heidelberg, Invited Speaker „Endovenous laser treatment”
  • 15. - 16. February, Bonner Venentage, Bonn,Invited Speaker „Endovenöse Lasertherapie der Stammvarikose“
  • 12. January, Mainzer Symposium, Endovenöse Laser-Therapie (EVLT) der Vena saphena magna .,Symposium Director, Speaker „Endovenöse Lasertherapie der Vena saphena magna“.

• 2001

  • 8. Dezember, 12. Symposium für Dermato-Onkologie und operative Dermatologie, Kiel, Speaker „Neue Entwicklungen in der operativen Therapie der Varikose“
  • 10th November, Annual Meeting of the American College of Phlebology, La Quinta Palm Springs, USA, Speaker, Panelist, “Endovenous Treatment of the GSV with a 940 nm Diode-Laser: Thrombotic Occlusion after Endoluminal Damage by Laser Generated Steam Bubbles”
  • 09.-14. September, 14th World Congress der Union International Phlebologique (UIP), Rome, Italy, Speaker “Subfascial endoscopic surgery of perforators (SEPS) for treatment of chronic venous ulcers”
  • 7. September, Annual Meeting of the German Society for Ästhetic Surgery (DGÄC), Heidelberg, Germany. Speaker “Endovenous Laser Treatment of the Greater Saphenous Vein with a 940 nm Diode-Laser”
  • 13. - 16. June, Fortbildungswoche für praktische Phlebologie, Berlin, Speaker, „Endoskopische Perforansdiszision und paratibiale Fasziotomie beim Ulcus cruris venosum“
  • 09. June, Conference Aesthetic Surgery, Bochum, Germany, Speaker „Scar Treatment“
  • 01. May, Biannual Meeting of the German Society of Dermatology, Berlin, Live-Surgery, “Saugkürettage der Hyperhidrosis axillaris”

• 2000

  • 16-19th November, 14th Annual Meeting of the American College of Phlebology, Atlanta, USA, Speaker “Performing SEPS with Tumescent Local Anesthesia (TLA) - the first 30 cases”
  • 09. - 12. November, 5. Live-Symposium for Dermatologic Surgery, Darmstadt, Speaker „Die Bedeutung der Tumeszenzanaesthesie in der Phlebologie“
  • 21. - 24. September, 21th Annual meeting of the International Society for Dermatological Surgery, Madrid, Spain, Speaker “Efficacy of ultrasound B-scan compared to physical examination in follow-up of melanoma patients.”

• 1999

  • 1. October, European Congress of the International Union of Phlebology, Annual Meeting, Bremen, Speaker “Endoscopic fasciotomy with or without subfascial endoscopic perforator surgery (SEPS) for treatment of chronic venous ulcers”
  • 24. September, 30th Annual EORTC-Melanoma-Cooperative-Group Symposium., Rotterdam, Netherlands, Speaker “Efficacy of ultrasound B-scan compared to physical examination in follow-up of melanoma patients”
  • 1. - 5. September, 20th Annual Meeting of the International Sciety of Dermatological Surgery, Athens, Greece, Speaker “Endoscopic fasciotomy with and without subfascial perforator surgery (SEPS) for treatment of chronic venous ulcer patients”

• 1998

  • 11. September, 13th World Congress der Union International Phlebologique (UIP), Sydney, Australia. Speaker “Light reflection rheography and clinical course of patients with advanced venous disease before and after endoscopic subfascial division of perforating veins”

• 1997

  • Jahrestagung der Deutschen Gesellschaft für Phlebologie, 1.-4. Oktober, Bonn. Speaker, Optische Plethysmographie und klinischer Verlauf vor und nach endoskopischer Perforansdiszision.